[go: up one dir, main page]

AU1430601A - Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders - Google Patents

Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders

Info

Publication number
AU1430601A
AU1430601A AU14306/01A AU1430601A AU1430601A AU 1430601 A AU1430601 A AU 1430601A AU 14306/01 A AU14306/01 A AU 14306/01A AU 1430601 A AU1430601 A AU 1430601A AU 1430601 A AU1430601 A AU 1430601A
Authority
AU
Australia
Prior art keywords
pdgf
methods
related protein
musculoskeletal disorders
treat musculoskeletal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14306/01A
Inventor
Gerald Wayne Becker
Lisa Janine Hammond
Janet Mary Hock
Alexei Kharitonenkov
Venkatesh Krishnan
Songqing Na
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1430601A publication Critical patent/AU1430601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU14306/01A 1999-11-02 2000-10-24 Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders Abandoned AU1430601A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16305699P 1999-11-02 1999-11-02
US16320499P 1999-11-02 1999-11-02
US16320399P 1999-11-02 1999-11-02
US60163203 1999-11-02
US60163204 1999-11-02
US60163056 1999-11-02
PCT/US2000/026272 WO2001032197A2 (en) 1999-11-02 2000-10-24 Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders

Publications (1)

Publication Number Publication Date
AU1430601A true AU1430601A (en) 2001-05-14

Family

ID=27388828

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14306/01A Abandoned AU1430601A (en) 1999-11-02 2000-10-24 Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders

Country Status (2)

Country Link
AU (1) AU1430601A (en)
WO (1) WO2001032197A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
ES2443581T3 (en) 2006-02-09 2014-02-19 Biomimetic Therapeutics, Llc Compositions and methods for bone treatment
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
ES2664229T3 (en) 2006-06-30 2018-04-18 Biomimetic Therapeutics, Llc Compositions and methods of biomatrix-PDGF for the treatment of rotator cuff injuries
CA2735885C (en) 2008-09-09 2018-08-28 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
BR112012020566B1 (en) 2010-02-22 2021-09-21 Biomimetic Therapeutics, Llc PLATELET-DERIVED GROWTH FACTOR COMPOSITION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149691A (en) * 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
ATE180674T1 (en) * 1993-03-29 1999-06-15 Zymogenetics Inc OSTEOBLAST GROWTH-SUPPORTING COMPOSITIONS THAT CONTAIN PDGF AND VITAMIN-D
AU2297395A (en) * 1994-04-20 1995-11-16 Institute Of Molecular Biology, Inc. Administration of platelet-derived growth factor and bone seeking drugs for osteoporosis and bone regeneration
WO1999047677A2 (en) * 1998-03-17 1999-09-23 Genentech, Inc. Polypeptides homologous to vegf and bmp1
ATE368739T1 (en) * 1998-12-22 2007-08-15 Janssen Pharmaceutica Nv VASCULAR ENDOTHELIAL GROWTH FACTOR X
WO2000059940A2 (en) * 1999-04-06 2000-10-12 Eli Lilly And Company Platelet-derived growth factor related gene and protein

Also Published As

Publication number Publication date
WO2001032197A2 (en) 2001-05-10
WO2001032197A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
EP1180015B8 (en) Generation of therapeutic microfoam
AU3920900A (en) Compounds and methods to treat cardiac failure and other disorders
AU6530600A (en) Use of neurotoxin for treating cardiac muscle disorders
AU2001273132A1 (en) Compounds to treat alzheimer's disease
HK1002725B (en) Showerhead with water-driven vibrator to provide massage effect
AU6367099A (en) Improved process for water treatment
AU3818300A (en) Treating hair by targeting enzymes
AU7882900A (en) Hydrotherapy bed
AU2002249779A1 (en) Method to treat hemophilia
ZA983376B (en) Process for the preparation of flupirtine maleate.
AU1430601A (en) Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders
AU2002217447A1 (en) Apparatus for lipolysis for aesthetic treatment
AU2001239510A1 (en) Treatment of renal disorders
AU2003253036A1 (en) Process for the preparation of optically active 3-n-methylamino-1-(2-thienyl)-1-propanol
AU7106300A (en) Treatment of skin disorders
AU2001280436A1 (en) Process to increase protein stability
AU2000238386A1 (en) Massaging machine
AU2080201A (en) Treatment of addiction disorders
AU2934200A (en) Massager for self-massage (auto-massager)
AU4232100A (en) Water powered massager
AU5667700A (en) Methods to detect protein trafficking disorders
AU2001272902A1 (en) Treating musculoskeletal disorders using lp85 and analogs thereof
AU8693298A (en) Ratite extracts as therapeutic agents
AU6234000A (en) Methods for treating autoimmune diseases
AU7434700A (en) Shower head

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase